# A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-novel-pi3k-inhibitor-displays-potent-preclinical-activity-against-an-androgen/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Min Shi,Xiumin Zhou,Zubin Zhang,Man Wang,Guodong Chen,Kunkun Han,Biyin Cao,Zhaopeng Liu,Xinliang Mao |
| Citations | 17 |
| DOI | 10.1016/j.toxlet.2014.05.003 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2073315906 |
| PMID | 24831963 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Min Shi](https://scholariq.org/researchers/min-shi/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Hippo pathway signaling and YAP/TAZ](https://scholariq.org/topics/hippo-pathway-signaling-and-yap-taz/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.